Logo


Ticker
Arrow Up NYSE Composite   NYSE   10890.25    +389.75 (+3.7%) Arrow Up Bank of America   BAC    17.62     +0.49 (+2.9%) Arrow Up Direx Small Cap Bull 3x E.T.F.   TNA    78.81     +7.82 (+11.0%) Arrow Up Mrk Vectr Russia E.T.F.   RSX    16.19     +0.39 (+2.5%) Arrow Up Oracle Corp.   ORCL    46.00     +6.05 (+15.1%) Arrow Up Rite Aid Corp.   RAD    6.77     +1.08 (+19.0%) Arrow Up SPDR S&P 500 E.T.F.   SPY    206.52     +5.63 (+2.8%) Arrow Up Talisman Energy   TLM    7.85     +3.56 (+83.0%) Arrow Up NASDAQ Composite   NASDAQ   4765.38    +111.78 (+2.4%) Arrow Up Apple   AAPL     111.78    +2.05 (+1.9%) Arrow Up Cirrus Logic   CRUS     22.73    +3.89 (+20.7%) Arrow Up FireEye, Inc.   FEYE     33.06    +3.94 (+13.5%) Arrow Up Herzfeld Caribbean Basin (D)   CUBA     11.67    +4.72 (+67.9%) Arrow Up Linn Energy Llc   LINE     12.24    +0.23 (+1.9%) Arrow Up Microsoft   MSFT     47.66    +0.71 (+1.5%) Arrow Up PowerSh QQQ E.T.F.   QQQ     104.32    +1.65 (+1.6%) Arrow Up Riverbed Technology   RVBD     20.33    +1.59 (+8.5%) Arrow Up Volcano Corp.   VOLC     17.88    +6.05 (+51.1%) Arrow Up NYSE AMEX Composite   AMEX   2466.16   +94.96 (+4.0%) Arrow Up NovaGold Resources   NG    3.12    +0.44 (+16.4%) Arrow Up Organovo Holdings   ONVO    7.24    +0.89 (+14.0%) Arrow Up S&P/TSX Composite   TSX   14468.26    +737.21 (+5.4%) Arrow Up Advantage Oil & Gas   AAV    5.96    +0.63 (+11.8%) Arrow Up Alimentation Couche-Tard   ATD.B    49.08    +8.24 (+20.2%) Arrow Up MAG Silver Corp.   MAG    8.94    +0.89 (+11.1%) Arrow Up Penn West Petroleum   PWT    2.62    +0.12 (+4.8%) Arrow Up Talisman Energy   TLM    9.14    +4.10 (+81.4%)

    

  (format: symbol-exchange code e.g. IBM-N)

Exchange Codes:  T-Toronto N-New York A-American Q-Nasdaq I-Index
close window
  • Stock Trends Report
  • Charting
  • Industry
  • Profile
NASDAQ BCRX
week ending
Friday Dec 19, 2014
   
Biocryst Pharmaceuticals
Trend Trend Counters Relative Strength  
Bullish Crossover (aka 'Newly Bullish' Trend). The stock's Trend Category has changed from BEARISH to BULLISH. The 13-week MA, which was below the 40-week MA a week previous, has now moved above it. A stock in this sub-category is in the 1st week of its new BULLISH Trend Category. Trading implications: often considered a good trade entry signal.
Trend / Category
1/ 1
13 week Current wk Unusual Volume
99 +
n/a
  weeks in vs. S&P500  
Trading stats for the Week ST Chart - click for more ST charts
  Close Range
$US 11.16 9.94 - 11.46
1 week %change 13 week %change
+10.9% +2.1%
Average Price
13 week MA 40 week MA
10.94 10.93
52-week range
6.88 - 14.62
Share Volume Transactions
6,224,200 35,825
Avg traded value Relative Volume
$1,939 10.4%
Total traded value
$69,462,072
1-week gain/loss exceeds 10%
Historical ST Data | ST Charts
Biocryst Pharmaceuticals (BCRX-Q)
Trend Rel
Str
+
-
52wk
Hi | Lo
Stock Name
Symbol
Wk Close
Wk
%Chg
Wk
Range
Vol (00's)
Trades
Biotechnology
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 2/2 57 - 6.36 | 1.51 22nd Century Group XXII 1.59 -1.2 1.51 - 1.72 18624 5998
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 13/14 120 - 33.49 | 15.64 ACADIA Pharmaceuticals ACAD 32.98 +1.4 29.00 - 33.49 80647 51648
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 21/60 53 + 1.56 | 0.35 Acasti Pharma (D) ACST 0.56 +3.7 0.49 - 0.61 11016 850
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 1/2 157 - 57.89 | 23.61 Acceleron Pharma XLRN 39.05 -6.5 37.18 - 42.38 26066 17072
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 6/27 120 + 15.31 | 2.45 Achillion Pharmaceuticals ACHN 14.21 +7.0 12.41 - 14.95 232813 104313
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 3/4 130 + 40.58 | 27.51 Acorda Therapeutics Inc. ACOR 40.06 +3.5 37.94 - 40.58 38230 25497
93 - 15.00 | 5.05 Actinium Pharmaceuticals ATNM 6.07 +2.0 5.55 - 6.40 6548 2583
0 - 14.00 | 9.55 Adma Biologics Inc. ADMA 10.55 -4.1 10.00 - 11.52 882 212
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 1/2 172 + 5.99 | 2.46 Advaxis ADXS 5.61 +48.4 3.85 - 5.79 36174 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 9540
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 11/49 67 + 74.58 | 19.10 Aegerion Pharmaceuticals AEGR 22.81 +8.2 19.96 - 23.57 44558 28515
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 5/6 44 - 1.62 | 0.48 AEterna Zentaris AEZS 0.61 +1.7 0.58 - 0.64 28944 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 4426
96 + 8.30 | 3.55 Affimed N.V. AFMD 6.10 +13.4 5.14 - 6.34 2495 1383
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 3/13 133 + 5.27 | 2.27 Agenus Inc. AGEN 3.99 +23.9 3.22 - 4.26 76234 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 24692
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 19/35 237 - 124.39 | 21.40 Agios Pharmaceuticals AGIO 119.62 +0.1 105.78 - 121.66 65883 49869
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 1/1 53 + 31.00 | 8.60 Akebia Therapeutics AKBA 11.90 +5.0 10.56 - 12.43 14924 7458
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 7/41 65 - 23.95 | 9.71 Albany Molecular Research AMRI 14.89 -6.0 13.73 - 15.95 44704 31200
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 12/30 24 + 25.44 | 3.12 Alcobra Ltd. ADHD 4.38 +28.5 3.27 - 4.51 14838 5983
221 + 30.02 | 9.50 Alder BioPharmaceuticals, Inc. ALDR 28.54 +12.9 23.72 - 30.02 22520 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 12795
98 - 11.99 | 3.00 Aldeyra Therapeutics ALDX 7.44 -4.6 6.72 - 7.90 367 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 234
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 32/79 114 - 203.30 | 126.76 Alexion Pharmaceuticals ALXN 189.53 +1.4 176.01 - 191.56 86419 77224
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 9/10 126 - 112.57 | 47.03 Alnylam Pharmaceuticals ALNY 100.73 +0.3 90.65 - 104.27 40817 31191
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 20/21 115 + 173.14 | 108.20 Amgen AMGN 170.17 +3.4 157.50 - 171.73 237045 183434
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 5/25 118 - 8.79 | 1.77 Amicus Therapeutics FOLD 8.03 -1.5 7.48 - 8.26 137030 46322
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 16/17 131 - 37.45 | 13.19 Anacor Pharmaceuticals, Inc. ANAC 33.41 -1.3 31.54 - 34.84 38894 22866
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 5/6 179 - 61.43 | 16.72 ANI Pharmaceuticals ANIP 54.16 -0.2 53.00 - 57.36 26758 16929
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 2/11 94 - 52.49 | 28.79 Anika Therapeutics ANIK 38.14 +1.8 35.85 - 39.16 12008 10646
0 - 3.18 | 2.02 Applied DNA Sciences APDN 2.70 +1.1 2.55 - 3.10 6564 2715
122 - 34.37 | 11.10 Applied Genetic Technologies AGTC 20.83 +3.2 19.65 - 21.42 3476 2491
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 6/33 160 + 25.50 | 9.20 Aratana Therapeutics PETX 16.43 +21.8 11.72 - 16.58 40175 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 20327
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 24/28 73 - 2.54 | 0.70 ARCA biopharma ABIO 0.97 -4.9 0.89 - 1.03 14229 2479
182 - 35.48 | 11.37 Ardelyx, Inc. ARDX 23.86 -21.4 21.13 - 28.22 7036 5111
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 5/22 93 - 7.97 | 3.26 Arena Pharmaceuticals ARNA 3.99 +2.1 3.63 - 4.10 212398 58902
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 8/22 121 + 9.83 | 4.90 ARIAD Pharmaceuticals ARIA 7.22 +13.9 6.03 - 7.32 330974 114012
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 1/74 96 - 2.92 | 1.04 Arqule Inc. ARQL 1.19 -4.8 1.11 - 1.24 21421 3981
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 5/53 125 - 5.64 | 2.98 Array BioPharma ARRY 4.86 nc 4.50 - 4.94 129196 42013
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 12/25 41 + 27.63 | 4.95 Arrowhead Research ARWR 6.39 +10.9 5.34 - 6.40 133955 50153
0 - 5.95 | 3.05 Asterias Biotherapeutics AST 3.24 -16.9 3.24 - 3.98 1895 923
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 4/29 94 - 4.33 | 1.08 Athersys Inc. ATHX 1.36 nc 1.15 - 1.43 25483 6479
161 - 54.17 | 22.00 Avalanche Biotechnologies AAVL 51.56 +2.1 48.09 - 52.56 15405 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 8991
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 23/165 65 + 2.07 | 0.61 AVEO Pharmaceuticals AVEO 0.85 +30.8 0.66 - 0.97 68576 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 10201
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 5/27 59 - 15.77 | 5.45 BIND Therapeutics BIND 5.50 -5.5 5.45 - 6.00 5977 3105
73 - 11.00 | 4.50 Bio Blast Pharma Ltd. ORPN 6.53 -2.7 6.00 - 7.45 675 266
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 10/25 97 - 97.15 | 82.51 Bio-Techne Corp. TECH 93.82 +0.8 89.43 - 94.37 12844 11899
Bullish Crossover (aka 'Newly Bullish' Trend). The stock's Trend Category has changed from BEARISH to BULLISH. The 13-week MA, which was below the 40-week MA a week previous, has now moved above it. A stock in this sub-category is in the 1st week of its new BULLISH Trend Category. Trading implications: often considered a good trade entry signal. 1/1 99 + 14.62 | 6.88 Biocryst Pharmaceuticals BCRX 11.16 +10.9 9.94 - 11.46 62242 35825
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 7/69 79 - 18.48 | 5.51 BioDelivery Sciences Intl. BDSI 13.82 nc 11.48 - 14.58 84209 46333
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 3/224 106 + 361.93 | 270.62 Biogen IDEC BIIB 360.67 +4.7 322.35 - 361.93 109859 101341
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 3/34 107 - 3.12 | 1.20 BioLineRx Ltd. BLRX 1.72 -0.6 1.62 - 1.89 24509 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 4518
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 10/11 130 - 96.36 | 55.04 Biomarin Pharmaceuticals BMRN 93.84 +2.5 85.72 - 94.19 83602 67349
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 45/85 115 + 42.00 | 20.32 BioSpecifics Technologies (D) BSTC 39.51 +5.1 36.06 - 40.24 2021 2168
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 1/29 104 + 7.07 | 2.10 Biota Holdings Ltd. BOTA 2.44 +5.2 2.26 - 2.50 11426 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 1826
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 1/9 85 + 4.14 | 2.21 Biotime Inc. BTX 3.33 +5.1 3.10 - 3.49 10600 4568
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 10/27 244 - 94.49 | 17.40 bluebird bio BLUE 92.00 +0.8 83.19 - 94.49 74602 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 52105
0 + 4.35 | 2.81 Brainstorm Cell Therapeutics BCLI 3.15 +8.6 2.81 - 3.49 4786 2383
0 - 33.48 | 6.51 Calithera Biosciences CALA 27.93 -6.4 21.50 - 33.48 42083 22677
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 3/4 107 - 24.45 | 15.20 Cambrex Corp. CBM 23.00 -2.8 22.90 - 24.10 12477 8611
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 1/18 92 - 9.46 | 2.29 Can-Fite BioPharma CANF 3.41 -2.3 3.24 - 4.00 8191 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 2480
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 4/8 108 - 23.25 | 7.53 Cara Therapeutics CARA 10.00 +0.6 9.34 - 10.42 10310 3458
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 18/23 65 - 2.34 | 1.07 CASI Pharmaceuticals, Inc. CASI 1.23 -12.1 1.07 - 1.41 2352 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 536
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 14/15 71 + 1.90 | 0.54 Cel Sci Corp CVM 0.65 +14.0 0.54 - 0.65 17162 2303
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 9/24 121 - 119.84 | 66.85 Celgene Corp. CELG 117.18 +2.4 108.26 - 118.73 355668 251565
Bullish Crossover (aka 'Newly Bullish' Trend). The stock's Trend Category has changed from BEARISH to BULLISH. The 13-week MA, which was below the 40-week MA a week previous, has now moved above it. A stock in this sub-category is in the 1st week of its new BULLISH Trend Category. Trading implications: often considered a good trade entry signal. 1/1 178 + 19.48 | 7.45 Celladon Corporation CLDN 18.61 +7.9 16.24 - 19.48 17805 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 8002
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 1/2 131 + 33.33 | 10.76 Celldex Therapeutics CLDX 18.92 +4.9 16.20 - 19.45 102916 54061
114 - 3.70 | 1.76 Cellectar Biosciences, Inc. CLRB 3.10 +0.3 3.06 - 3.70 2855 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 1383
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 24/35 69 + 22.49 | 4.72 Cellular Dynamics Int'l ICEL 6.49 +25.1 5.05 - 6.70 8273 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 2587
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 21/57 78 - 4.74 | 2.30 Celsion Corporation (D) CLSN 2.42 nc 2.30 - 2.50 3536 1225
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 7/8 81 - 9.20 | 4.63 Celsus Therapeutics CLTX 4.90 -6.5 4.87 - 5.39 92 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 70
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 8/9 209 + 21.45 | 8.10 Cempra, Inc. CEMP 21.31 +12.2 18.05 - 21.45 37761 22799
149 - 8.06 | 3.35 Cerulean Pharma Inc. CERU 6.01 +0.2 5.30 - 6.42 1391 820
Bullish Crossover (aka 'Newly Bullish' Trend). The stock's Trend Category has changed from BEARISH to BULLISH. The 13-week MA, which was below the 40-week MA a week previous, has now moved above it. A stock in this sub-category is in the 1st week of its new BULLISH Trend Category. Trading implications: often considered a good trade entry signal. 1/1 155 + 8.00 | 3.48 Cerus Corp. CERS 6.41 +31.6 4.58 - 6.93 195616 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 76492
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 2/30 144 + 8.50 | 4.06 ChemoCentryx Inc. (D) CCXI 7.20 +28.6 5.61 - 7.40 43194 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 18316
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 29/40 145 + 41.28 | 14.02 Chimerix, Inc. CMRX 40.86 +15.3 33.60 - 41.28 32182 21632
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 44/123 121 - 71.13 | 26.66 China Biologic Products CBPO 67.14 +3.3 60.01 - 67.48 2347 2567
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 7/73 70 - 1.27 | 0.33 Cleveland BioLabs (D) CBLI 0.34 nc 0.33 - 0.38 10417 2831
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 1/2 123 - 93.33 | 35.33 Clovis Oncology CLVS 56.64 +2.7 51.52 - 58.71 36249 28551
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 3/19 103 + 3.30 | 1.24 Codexis, Inc. CDXS 2.50 +6.4 2.26 - 2.69 9039 3303
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 2/31 94 + 14.32 | 6.27 Compugen Ltd. CGEN 8.83 +6.8 7.85 - 9.05 26682 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 9042
Bullish Crossover (aka 'Newly Bullish' Trend). The stock's Trend Category has changed from BEARISH to BULLISH. The 13-week MA, which was below the 40-week MA a week previous, has now moved above it. A stock in this sub-category is in the 1st week of its new BULLISH Trend Category. Trading implications: often considered a good trade entry signal. 1/1 112 - 15.67 | 5.06 Conatus Pharmaceuticals CNAT 7.33 -7.7 7.10 - 8.18 14916 7036
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 1/6 88 + 16.26 | 7.12 Concert Pharmaceuticals CNCE 12.72 +13.4 10.31 - 13.05 20823 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 11429
63 + 5.50 | 2.50 ContraFect Corp. CFRX 2.80 +3.7 2.52 - 2.98 609 141
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 2/3 108 - 4.49 | 1.69 Corcept Therapeutics CORT 3.16 -7.9 2.91 - 3.47 11914 6705
114 + 8.49 | 4.30 Corium International CORI 7.85 +34.0 5.41 - 7.87 496 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 107
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 12/23 80 + 3.20 | 0.91 CorMedix Inc. CRMD 1.54 +10.8 1.30 - 1.54 1364 444
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 3/4 110 - 3.31 | 1.45 Coronado Biosciences CNDO 2.20 +0.9 1.88 - 2.27 12980 3661
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 2/21 88 - 4.25 | 1.75 CTI BioPharma Corp. CTIC 2.44 +1.7 2.21 - 2.51 107790 25631
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 4/5 144 - 101.03 | 58.50 Cubist Pharmaceuticals CBST 98.67 +2.5 96.06 - 99.25 126366 76704
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 3/54 75 - 3.40 | 1.09 Curis Inc CRIS 1.17 -0.9 1.09 - 1.28 54060 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 10210
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 8/36 21 - 4.84 | 0.61 Cyclacel Pharmaceuticals CYCC 0.68 -76.9 0.61 - 2.98 78489 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 8292
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 7/31 115 - 13.26 | 3.05 Cytokinetics Inc. (D) CYTK 4.89 +2.3 4.43 - 4.95 10661 5371
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 29/30 50 - 3.47 | 0.36 Cytori Therapeutics (D) CYTX 0.51 -3.8 0.45 - 0.57 94758 15780
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 24/32 90 + 8.35 | 2.08 Cytrx Corp. CYTR 2.55 +11.4 2.08 - 2.71 49286 16508
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 18/35 72 + 4.40 | 0.74 DARA Biosciences (D) DARA 0.88 +7.3 0.75 - 0.89 16816 3147
0 - 22.94 | 12.68 Dermira, Inc. DERM 20.29 +1.5 19.51 - 22.94 18363 7516
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 2/8 124 + 46.00 | 8.00 Dicerna Pharmaceuticals DRNA 16.79 +30.4 12.25 - 16.82 35944 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 12988
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 2/2 105 - 15.86 | 8.00 Dipexium Pharmaceuticals DPRX 11.11 -4.0 10.97 - 11.69 872 508
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 8/32 70 - 2.77 | 0.99 Discovery Laboratories DSCO 1.26 -5.3 1.19 - 1.38 12709 3766
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 20/21 142 + 15.53 | 6.05 Dyax DYAX 15.31 +8.0 13.11 - 15.53 99385 50195
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 7/7 52 - 19.85 | 3.81 Egalet Corporation EGLT 5.30 -15.3 5.00 - 5.89 710 532
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 2/7 96 + 19.33 | 9.50 Eleven Biotherapeutics EBIO 11.87 +3.6 11.33 - 12.10 2609 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 1044
Bullish Crossover (aka 'Newly Bullish' Trend). The stock's Trend Category has changed from BEARISH to BULLISH. The 13-week MA, which was below the 40-week MA a week previous, has now moved above it. A stock in this sub-category is in the 1st week of its new BULLISH Trend Category. Trading implications: often considered a good trade entry signal. 1/1 120 + 28.48 | 19.31 Emergent BioSolutions EBS 27.05 +3.9 24.75 - 27.85 17906 11729
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 19/53 115 + 49.09 | 27.00 Enanta Pharmaceuticals ENTA 46.62 +7.8 40.56 - 47.17 32562 17493
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 12/27 83 - 33.70 | 5.31 Endocyte, Inc. ECYT 6.24 -0.2 5.84 - 6.55 32996 17213
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 1/2 93 - 1.83 | 0.78 Enzon, Inc. ENZN 1.03 -5.5 1.02 - 1.12 14111 4386
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 5/26 98 - 30.78 | 6.34 Enzymotec Ltd. ENZY 7.76 -3.0 6.64 - 7.90 1491 1004
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 24/55 70 + 22.50 | 3.78 EPIRUS Biopharmaceuticals EPRS 5.40 +12.5 4.69 - 5.65 1318 757
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 3/4 73 + 41.23 | 16.51 Epizyme, Inc. EPZM 19.98 +8.9 16.51 - 20.07 32328 18073
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 21/23 228 - 40.00 | 12.52 Esperion Therapeutics Inc ESPR 38.30 +2.2 33.75 - 38.93 19075 11648
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 18/18 70 - 20.17 | 8.74 Evogene Ltd. EVGN 10.00 -2.3 9.60 - 10.41 153 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 97
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 31/50 132 - 29.97 | 10.69 EXACT Sciences EXAS 25.97 -7.1 24.85 - 28.69 151291 81636
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 16/35 76 - 8.41 | 1.28 Exelixis Inc EXEL 1.33 -5.0 1.29 - 1.44 245275 45561
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 1/25 98 + 13.55 | 3.50 Fate Therapeutics FATE 5.27 +42.8 3.50 - 5.90 4183 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 1963
0 - 31.48 | 20.10 FibroGen, Inc. FGEN 27.46 -5.3 25.77 - 31.48 25970 10054
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 1/2 219 + 26.24 | 10.50 Five Prime Therapeutics FPRX 25.89 +17.0 20.91 - 26.24 26526 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 12416
97 - 11.00 | 4.75 Foamix Pharmaceuticals Ltd. FOMX 6.14 -4.4 5.59 - 6.45 5098 2264
0 + 26.03 | 15.75 Forward Pharma A/S FWP 21.40 +7.2 19.92 - 21.50 3401 2009
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 19/34 70 - 7.77 | 1.51 Galena Biopharma GALE 1.57 -7.1 1.51 - 1.70 78476 15702
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 2/2 81 + 18.73 | 4.58 Galmed Pharmaceuticals GLMD 5.52 +12.7 4.58 - 6.85 3258 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 1641
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 7/7 63 - 23.99 | 7.00 Genocea Biosciences GNCA 7.53 -9.4 7.20 - 8.39 861 569
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 1/26 103 + 4.25 | 1.61 Genvec, Inc. GNVC 2.20 +20.2 1.81 - 2.20 1827 705
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 3/4 141 - 5.59 | 1.31 Geron Corp GERN 3.26 +0.6 2.91 - 3.32 222518 52719
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 3/155 99 + 116.83 | 63.50 Gilead Sciences GILD 108.45 +4.2 99.56 - 109.49 783074 452056
74 - 15.00 | 4.29 GlobeImmune, Inc. GBIM 6.67 -9.9 6.54 - 7.67 569 242
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 2/68 117 + 2.35 | 0.41 GTx Inc. (D) GTXI 0.89 +25.4 0.71 - 0.98 27674 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 5451
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 1/34 94 + 18.18 | 6.88 Halozyme Therapeutics HALO 9.46 +18.4 7.51 - 10.00 123727 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 60684
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 7/9 60 - 9.59 | 3.60 Heat Biologics HTBX 3.97 +2.1 3.90 - 4.25 1002 638
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 9/23 71 - 0.55 | 0.22 Hemispherx Biopharma Inc HEB 0.24 -4.0 0.22 - 0.25 41972 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 6709
0 - 12.97 | 10.25 Histogenics Corporation HSGX 11.00 nc 10.25 - 11.25 3659 1739
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 12/19 91 + 32.98 | 19.59 Hyperion Therapeutics HPTX 22.97 +4.9 21.32 - 23.04 20120 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 11563
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 4/14 113 + 3.48 | 0.24 iBio, Inc. IBIO 0.72 +4.4 0.58 - 0.75 38899 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 6023
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 4/28 163 + 6.87 | 1.94 Idera Pharmaceuticals (D) IDRA 4.12 +7.3 3.43 - 4.25 107731 35810
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 1/94 128 + 11.28 | 2.86 IGI Laboratories Inc. IG 9.92 +13.0 8.43 - 10.00 83151 41072
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 2/2 93 - 10.64 | 5.36 Ignyta, Inc. RXDX 6.78 +0.4 6.28 - 6.96 798 492
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 10/112 107 - 197.37 | 105.26 Illumina Inc. ILMN 189.97 +3.1 172.09 - 190.40 68641 64288
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 10/22 91 - 5.68 | 3.30 Immucell Corp ICCC 5.01 +1.6 4.71 - 5.12 106 66
264 + 36.69 | 11.51 Immune Design Corp. IMDZ 33.06 +47.9 21.36 - 33.81 1803 1640
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 1/53 70 - 1.58 | 0.53 ImmunoCellular Therapeutics IMUC 0.72 -12.2 0.70 - 0.82 13511 2260
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 26/58 52 - 17.80 | 5.36 Immunogen Inc. IMGN 6.11 -39.0 5.36 - 11.00 211398 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 87999
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 2/3 133 - 6.17 | 3.04 Immunomedics IMMU 4.48 -2.2 4.08 - 4.64 49362 20745
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 22/41 106 - 9.62 | 3.11 Imprimis Pharmaceuticals IMMY 8.30 +2.9 8.00 - 8.75 1344 534
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 5/6 151 - 80.78 | 40.30 Incyte Corporation INCY 76.86 +3.0 71.02 - 77.85 81753 61070
Bullish Crossover (aka 'Newly Bullish' Trend). The stock's Trend Category has changed from BEARISH to BULLISH. The 13-week MA, which was below the 40-week MA a week previous, has now moved above it. A stock in this sub-category is in the 1st week of its new BULLISH Trend Category. Trading implications: often considered a good trade entry signal. 1/1 97 - 5.60 | 5.60 Indevus Pharmaceuticals Inc IDEV 5.60 nc nt nt nt
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 12/13 123 - 18.25 | 8.40 Infinity Pharmaceuticals INFI 17.73 -0.3 15.21 - 17.78 45875 30644
Bullish Crossover (aka 'Newly Bullish' Trend). The stock's Trend Category has changed from BEARISH to BULLISH. The 13-week MA, which was below the 40-week MA a week previous, has now moved above it. A stock in this sub-category is in the 1st week of its new BULLISH Trend Category. Trading implications: often considered a good trade entry signal. 1/1 90 + 15.80 | 7.48 Inovio Pharmaceuticals, Inc. INO 9.48 +11.7 8.17 - 9.60 61470 16347
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 1/31 121 + 22.29 | 11.25 Insmed, Inc. INSM 16.42 +16.2 13.60 - 16.58 49376 26203
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 8/9 131 + 57.91 | 20.52 Insys Therapeutics INSY 45.34 +10.6 39.81 - 47.18 28176 21611
Bullish Crossover (aka 'Newly Bullish' Trend). The stock's Trend Category has changed from BEARISH to BULLISH. The 13-week MA, which was below the 40-week MA a week previous, has now moved above it. A stock in this sub-category is in the 1st week of its new BULLISH Trend Category. Trading implications: often considered a good trade entry signal. 1/1 135 + 38.50 | 13.13 Intrexon Corp. XON 28.02 +3.7 25.58 - 28.65 48496 28301
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 10/220 100 - 183.84 | 120.38 Jazz Pharmaceuticals JAZZ 169.03 +2.4 158.38 - 170.56 45166 36786
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 2/20 107 - 18.48 | 11.53 Keryx Biopharmaceuticals KERX 14.79 +2.0 13.33 - 15.08 79590 48426
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 15/15 66 - 26.99 | 5.98 Kindred Biosciences KIN 6.88 +3.2 6.37 - 7.00 8234 5623
205 - 57.87 | 21.00 Kite Pharma KITE 53.58 -2.2 50.51 - 57.87 74622 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 42303
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 8/8 219 + 20.41 | 6.17 La Jolla Pharmaceutical (D) LJPC 20.15 +45.9 13.61 - 20.41 21865 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 10968
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 18/52 58 - 2.06 | 0.80 Lexicon Pharmaceuticals LXRX 0.86 +1.2 0.80 - 0.94 214341 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 41653
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 2/20 104 - 80.42 | 41.99 Ligand Pharmaceuticals LGND 52.32 -0.4 51.00 - 54.05 19623 16499
122 + 16.45 | 10.00 Loxo Oncology, Inc. LOXO 13.67 +22.8 11.07 - 14.36 2678 1603
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 1/54 96 + 5.30 | 2.30 Lpath Inc. LPTN 3.15 +10.5 2.60 - 3.15 4423 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 590
93 - 10.20 | 6.82 Macrocure Ltd. MCUR 7.50 nc 7.45 - 7.78 2129 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 314
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 1/2 155 + 41.00 | 17.31 MacroGenics, Inc. MGNX 34.53 +16.3 28.06 - 35.58 33330 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 19079
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 9/10 84 + 11.48 | 3.80 MannKind MNKD 5.36 +4.9 4.96 - 5.45 264419 75280
134 + 10.58 | 5.49 Marinus Pharmaceuticals MRNS 8.65 +13.4 6.70 - 8.75 631 301
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 18/19 78 - 1.10 | 0.40 Mast Therapeutics, Inc. MSTX 0.45 -4.3 0.43 - 0.48 32296 5816
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 2/17 103 + 9.00 | 3.68 Medgenics, Inc. MDGN 5.73 +11.9 5.00 - 5.73 8837 3687
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 1/15 102 - 5.25 | 1.66 Medicinova MNOV 3.11 -13.6 3.11 - 3.62 795 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 336
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 25/26 103 - 117.23 | 54.37 Medivation MDVN 108.34 +1.4 101.37 - 111.39 69759 49691
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 1/1 86 - 19.31 | 4.60 MediWound Ltd. MDWD 6.10 -9.5 6.01 - 6.75 3595 1220
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 17/47 147 + 11.05 | 4.13 Merrimack Pharmaceuticals MACK 11.04 +3.8 9.61 - 11.05 131024 61123
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 1/7 86 + 2.59 | 1.01 Merus Labs International MSLI 1.65 +28.9 1.23 - 1.65 2895 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 1390
89 + 7.90 | 4.08 Minerva Neurosciences NERV 5.67 +26.0 4.50 - 6.91 620 276
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 1/16 100 + 25.97 | 13.69 Mirati Therapeutics Inc MRTX 18.84 +20.2 15.45 - 19.70 3122 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 2256
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 7/25 106 - 22.44 | 7.80 NanoString Technologies NSTG 13.76 +1.3 12.70 - 14.96 3861 2884
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 2/61 131 + 2.12 | 0.97 Navidea Biopharmaceuticals NAVB 1.79 +20.1 1.41 - 1.88 92418 20127
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 9/20 119 - 17.53 | 10.10 Nektar Therapeutics NKTR 15.69 +2.5 14.29 - 15.96 71151 42954
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 5/37 62 - 8.29 | 3.08 Neostem NBS 3.34 -6.7 3.12 - 3.60 16682 7000
0 - 14.10 | 6.34 Neothetics, Inc. NEOT 6.57 -12.3 6.34 - 8.00 3575 1590
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 2/55 88 - 3.61 | 1.11 Neptune Tech & Bioresources NEPT 1.92 -2.0 1.84 - 2.01 5231 2111
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 13/14 83 + 4.81 | 2.12 Neuralstem CUR 2.85 +10.5 2.30 - 2.86 36541 13223
0 - 9.45 | 5.67 NeuroDerm Ltd. NDRM 5.80 -19.3 5.67 - 7.12 2122 1049
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 6/7 152 + 53.48 | 17.32 NewLink Genetics Corp. NLNK 40.11 +12.4 32.50 - 40.29 27690 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 19130
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 1/12 102 + 10.64 | 3.52 Northwest Biotherapeutics Inc NWBO 5.74 +15.3 4.85 - 5.77 26378 11553
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 18/52 84 - 1.47 | 0.53 NovaBay Pharmaceuticals NBY 0.67 -2.9 0.62 - 0.74 6208 1223
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 6/7 131 + 6.95 | 3.34 Novavax Inc. NVAX 5.97 +3.7 5.51 - 6.14 215660 67397
Bullish Crossover (aka 'Newly Bullish' Trend). The stock's Trend Category has changed from BEARISH to BULLISH. The 13-week MA, which was below the 40-week MA a week previous, has now moved above it. A stock in this sub-category is in the 1st week of its new BULLISH Trend Category. Trading implications: often considered a good trade entry signal. 1/1 129 + 39.68 | 22.11 NPS Pharmaceuticals NPSP 36.04 +15.2 29.50 - 37.50 114869 73442
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 1/31 106 - 19.94 | 4.47 Ocera Therapeutics OCRX 5.99 -1.8 5.50 - 6.14 2657 1637
145 + 21.88 | 11.90 Ocular Therapeutix, Inc. OCUL 21.74 +11.7 18.38 - 21.88 4133 3208
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 4/27 113 - 20.00 | 6.01 Ohr Pharmaceutical OHRP 8.74 +2.2 7.82 - 8.76 5147 2757
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 8/68 170 - 23.63 | 9.76 Omeros OMER 23.13 +1.4 20.25 - 23.30 23883 14025
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 30/31 70 - 14.25 | 1.98 OncoGenex Pharmaceuticals OGXI 2.03 -11.7 1.98 - 2.43 27088 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 6674
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 7/82 73 - 2.07 | 0.40 Oncolytics Biotech (D) ONCY 0.55 -9.8 0.50 - 0.62 18760 2939
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 1/27 122 + 42.34 | 16.57 OncoMed Pharmaceuticals OMED 21.48 +8.7 18.00 - 21.98 11240 8822
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 15/35 83 - 16.22 | 3.50 Onconova Therapeutics ONTX 3.99 +3.4 3.80 - 4.19 10496 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 2953
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 1/14 84 - 4.08 | 1.52 Oncothyreon Inc. ONTY 1.80 -10.9 1.68 - 2.12 80519 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 26404
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 1/2 97 - 124.70 | 124.70 Onyx Pharmaceuticals ONXX 124.70 nc nt nt nt
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 24/37 74 + 2.20 | 0.70 Opexa Therapeutics (D) OPXA 0.83 +7.8 0.70 - 0.86 6020 1001
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 12/26 117 - 50.00 | 28.60 Ophthotech Corporation OPHT 47.00 -3.8 45.12 - 49.78 26292 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 17661
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 1/35 72 + 4.65 | 0.74 Oragenics Inc. OGEN 1.03 +28.8 0.81 - 1.24 1362 447
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 16/30 63 - 31.73 | 4.88 Oramed Pharmaceuticals ORMP 5.41 -9.8 4.88 - 6.08 3371 1341
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 1/18 103 + 18.41 | 11.80 Osiris Therapeutics OSIR 14.33 +10.9 12.65 - 14.98 7997 5935
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 17/18 309 + 49.94 | 5.51 Ovascience Inc. OVAS 47.85 +46.3 26.02 - 49.94 47278 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 33183
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 7/24 70 - 5.40 | 1.48 Oxigene, Inc. OXGN 1.62 -5.3 1.48 - 1.74 24785 5876
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 6/7 145 + 8.20 | 3.87 Pacific Biosc. of California PACB 7.50 +10.1 6.41 - 7.50 34722 18628
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 18/19 48 + 6.22 | 1.61 Pain Therapeutics Inc PTIE 2.06 +10.8 1.80 - 2.13 11476 3928
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 3/4 351 + 38.50 | 8.99 Paratek Pharmaceuticals, Inc. PRTK 38.10 +31.2 27.07 - 38.50 4852 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 2567
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 8/9 94 + 10.26 | 7.22 PDL BioPharma PDLI 7.74 +4.5 7.23 - 7.97 178341 67521
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 7/18 94 - 3.18 | 1.26 Peregrine Pharmaceuticals PPHM 1.42 -4.1 1.34 - 1.50 48469 9681
103 + 8.53 | 5.28 Pfenex Inc. PFNX 7.03 +9.0 6.27 - 7.46 1027 574
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 9/14 103 - 154.89 | 82.51 Pharmacyclics PCYC 131.45 -0.9 125.58 - 134.48 54096 37893
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 3/13 105 + 2.59 | 1.19 PharmAthene PIP 1.84 +7.0 1.58 - 1.92 8201 2548
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 8/29 83 - 4.63 | 2.42 Pluristem Therapeutics PSTI 2.50 -3.9 2.45 - 2.60 6485 2108
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 15/19 113 + 31.48 | 19.59 Portola Pharmaceuticals PTLA 30.71 +8.6 26.76 - 31.38 35584 17310
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 15/32 86 - 13.29 | 1.40 Prana Biotechnology Ltd PRAN 1.87 +0.5 1.67 - 2.01 23853 4988
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 18/19 80 - 1.95 | 0.74 Prima BioMed PBMD 0.87 -1.1 0.74 - 0.90 364 69
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 7/17 139 - 7.57 | 3.10 Progenics Pharmaceutical PGNX 7.25 +2.1 6.85 - 7.57 105266 31870
120 + 21.87 | 11.00 ProQR Therapeutics N.V. PRQR 20.25 +7.8 16.08 - 21.00 6329 4269
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 10/29 211 - 22.80 | 4.12 Prosensa Holding N.V. RNA 18.78 +0.1 17.90 - 19.10 16029 9010
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 31/32 76 - 5.30 | 1.86 Protalix BioTherapeutics PLX 1.95 -7.1 1.89 - 2.14 10576 4113
0 + 12.00 | 8.57 Proteon Therapeutics, Inc. PRTO 10.19 +4.1 8.80 - 10.35 3851 1696
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 3/27 89 + 49.24 | 16.71 Prothena Corporation plc PRTA 21.55 +18.7 17.52 - 21.82 17840 12547
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 22/23 134 - 57.50 | 14.51 PTC Therapeutics PTCT 56.69 +1.5 48.07 - 57.50 36070 24867
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 1/20 79 + 279.37 | 53.63 Puma Biotechnology PBYI 221.30 +12.7 191.14 - 231.90 18848 18554
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 14/23 69 + 7.10 | 3.35 QLT Inc. QLTI 3.70 +5.1 3.35 - 3.82 24995 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 6817
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 19/20 203 + 135.37 | 24.53 Receptos, Inc. RCPT 133.61 +11.3 109.88 - 133.90 49420 33087
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 3/3 82 + 9.88 | 2.36 Recro Pharma REPH 2.71 +5.9 2.36 - 2.84 3569 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 613
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 24/25 82 - 14.10 | 0.80 Regado BioSciences RGDO 0.86 -3.4 0.83 - 0.91 14738 4102
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 23/24 116 - 437.64 | 262.97 Regeneron Pharmaceuticals REGN 427.64 +2.7 388.16 - 432.46 47518 52349
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 7/8 232 + 25.60 | 5.40 Regulus Therapeutics Inc RGLS 16.78 +4.5 14.74 - 17.28 52685 19266
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 3/39 96 - 3.00 | 1.14 Reliv' International RELV 1.23 +3.4 1.15 - 1.24 497 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 307
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 5/19 138 - 52.74 | 17.60 Relypsa, Inc. RLYP 32.03 -1.3 30.76 - 35.00 42374 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 26464
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 1/121 106 - 26.75 | 11.70 Repligen Corp. RGEN 21.42 -3.2 19.90 - 22.00 25200 17141
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 1/52 98 + 22.57 | 5.92 Repros Therapeutics RPRX 9.15 +4.7 8.04 - 9.50 41818 20721
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 7/7 85 - 39.86 | 14.02 Revance Therapeutics RVNC 17.65 +1.2 16.09 - 18.24 25410 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 8581
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 12/22 101 - 1.85 | 0.44 Rexahn Pharmaceuticals RNN 0.74 nc 0.69 - 0.76 37423 5110
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 26/52 41 - 1.35 | 0.13 Rock Creek Pharmaceuticals RCPI 0.14 -6.7 0.13 - 0.16 40072 4001
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 1/1 74 - 8.47 | 3.41 Ruthigen, Inc. RTGN 3.52 -8.1 3.41 - 4.09 358 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 165
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 1/6 69 - 6.84 | 0.32 RXI Pharmaceuticals RXII 1.60 -20.8 1.55 - 2.10 19557 4308
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 2/27 130 - 24.69 | 9.39 Sangamo BioSciences SGMO 15.36 -7.1 14.06 - 16.60 82970 44006
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 8/17 59 - 40.00 | 12.58 Sarepta Therapeutics, Inc. SRPT 13.21 -5.4 12.58 - 14.17 83569 49434
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 12/31 79 - 55.99 | 30.50 Seattle Genetics Inc SGEN 32.89 +2.0 30.50 - 33.94 117717 59685
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 3/4 111 - 4.19 | 2.02 Sequenom Inc. SQNM 3.60 -1.9 3.34 - 3.75 74569 26772
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 2/100 82 - 264.98 | 137.45 Shire plc SHPG 216.73 +1.4 207.72 - 221.20 59503 48909
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 3/52 108 - 3.87 | 0.99 SIGA Technologies (Q) SIGA 1.44 -4.6 1.35 - 1.55 12081 3514
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 8/27 96 - 8.14 | 4.51 Sinovac Biotech SVA 4.83 -1.4 4.66 - 5.02 8451 3265
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 3/22 166 + 16.40 | 3.10 Sorrento Therapeutics SRNE 8.50 +46.6 6.11 - 8.80 56392 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 20794
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 2/3 86 - 10.32 | 6.36 Spectrum Pharmaceuticals Inc SPPI 7.17 +1.0 6.90 - 7.29 62745 26319
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 10/11 72 - 2.43 | 0.84 StemCells, Inc. STEM 0.96 -5.9 0.84 - 1.00 60573 8728
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 10/51 118 - 31.48 | 10.50 Stemline Therapeutics STML 15.57 -5.6 15.18 - 16.72 6107 4705
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 7/8 33 + 8.46 | 1.00 Sunesis Pharmaceuticals SNSS 2.53 +12.0 2.19 - 2.65 82119 26406
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 10/19 143 + 119.42 | 60.19 Synageva BioPharma GEVA 95.46 +4.6 83.55 - 98.38 17292 15572
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 23/38 77 - 7.22 | 2.54 Synta Pharmaceuticals SNTA 2.80 -2.4 2.54 - 2.90 63454 21091
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 14/26 84 - 3.64 | 1.16 Synthetic Biologics Inc. SYN 1.52 +3.4 1.39 - 1.60 23145 5596
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 1/51 102 + 5.23 | 2.25 Targacept TRGT 2.76 +12.2 2.35 - 2.79 11249 4134
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 13/27 87 - 8.58 | 3.34 Tenax Therapeutics, Inc. TENX 3.79 +2.7 3.75 - 3.99 5411 2269
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 3/4 128 - 40.99 | 22.15 TESARO, Inc. TSRO 37.57 +0.6 33.65 - 38.00 26213 16971
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 5/15 125 - 14.75 | 3.51 TetraLogic Pharmaceuticals TLOG 4.83 -19.8 4.26 - 6.10 9743 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 4169
142 - 18.88 | 7.20 TG Therapeutics TGTX 16.45 -9.9 15.06 - 18.65 54879 32394
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 22/51 79 + 32.88 | 12.56 Theravance THRX 15.22 +13.7 12.63 - 15.46 97816 49296
52 - 35.68 | 13.11 Theravance Biopharma TBPH 14.03 +0.9 13.11 - 14.79 35860 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 18274
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 13/36 67 - 5.93 | 2.58 Threshold Pharmaceuticals THLD 3.07 +0.7 2.90 - 3.14 31369 12748
79 + 30.00 | 9.67 Tokai Pharmaceuticals, Inc. TKAI 14.87 +4.4 13.52 - 15.27 14770 5767
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 3/18 94 + 8.22 | 4.36 Transition Therapeutics Inc TTHI 6.84 +6.1 6.39 - 6.85 599 248
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 8/8 87 + 9.95 | 3.80 Trevena, Inc. TRVN 5.30 +32.2 4.10 - 5.30 11290 5243
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 1/7 87 + 7.10 | 2.97 Trovagene, Inc. TROV 4.54 +3.4 4.12 - 4.73 3002 1110
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 1/8 86 + 69.77 | 32.02 Ultragenyx Pharmaceutical RARE 48.38 +16.6 39.13 - 48.79 26834 16723
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 5/13 99 - 19.25 | 8.34 Vanda Pharmaceuticals VNDA 12.25 -3.7 12.08 - 13.06 34469 23566
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 2/21 98 - 7.45 | 1.90 VBI Vaccines Inc. VBIV 3.15 -9.5 3.12 - 3.60 5728 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 886
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 1/17 79 + 19.00 | 6.01 Veracyte, Inc. VCYT 8.34 +12.0 7.15 - 8.45 4182 3309
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 1/2 89 - 16.60 | 7.10 Verastem, Inc. VSTM 8.44 -6.1 8.02 - 9.14 19111 12011
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 2/17 102 - 7.00 | 2.55 Vericel Corporation VCEL 2.87 -1.0 2.76 - 3.00 3200 1278
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 23/24 111 - 124.35 | 59.79 Vertex Pharmaceuticals VRTX 118.90 +0.3 108.70 - 124.35 150835 106682
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 7/30 90 - 1.79 | 0.89 Vical Inc. VICL 1.07 -0.9 0.89 - 1.09 39453 6671
0 - 23.35 | 5.41 Vitae Pharmaceuticals, Inc. VTAE 21.81 -0.9 19.13 - 23.28 19956 9824
123 + 35.20 | 10.66 Vital Therapies VTL 25.41 +22.6 20.64 - 25.94 7647 5076
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 26/66 77 + 9.80 | 2.92 Vivus Inc. VVUS 3.32 +10.7 3.01 - 3.36 157782 48790
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 5/6 167 + 17.65 | 7.77 Xencor, Inc. XNCR 16.62 +41.1 11.22 - 17.65 17744 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 8947
0 - 18.00 | 12.06 Xenon Pharmaceuticals XENE 15.60 -8.5 14.69 - 18.00 2352 1532
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 9/10 148 - 9.24 | 3.15 XenoPort XNPT 8.20 -1.2 7.38 - 8.50 60039 26122
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 1/32 86 - 9.57 | 3.42 Xoma Corp. XOMA 4.01 -14.3 4.00 - 4.75 246051 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 64212
132 + 26.00 | 16.01 Zafgen, Inc. ZFGN 25.84 +14.5 20.98 - 26.00 11052 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 5231
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 9/31 160 + 5.58 | 2.31 ZIOPHARM Oncology ZIOP 4.80 +10.9 3.92 - 4.84 47545 18156
Highlighted stocks traded at their 52 week high or low, OR gained/lost more than 10% during the trading week.
Business Description :
BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small molecule pharmaceuticals that block key enzymes involved in the pathogenesis of diseases. The company integrates the disciplines of biology, crystallography, medicinal chemistry, and computer modeling to discover and develop drugs through the structure-guided drug design process. Its product candidates include peramivir, an intravenous neuraminidase inhibitor, which is approved for seasonal influenza in Japan and Korea, as well as to treat acute influenza; ulodesine, an oral purine nucleoside phosphorylase inhibitor, which has completed Phase II clinical trials for the treatment of gout; and forodesine, an oral purine nucleoside phosphorylase inhibitor that is in Phase II clinical trials for oncology. The companys product candidates also comprise BCX4161, a Phase II oral serine protease inhibitor for hereditary angioedema (HAE); and BCX4430, a preclinical, RNA dependent-RNA polymerase inhibitor for treating Filoviruses, including hemorrhagic fever viruses. Its pre-clinical products also include Two 2nd generation HAE compounds for the prevention of HAE attacks. It has collaborative relationships with Mundipharma International Holdings Limited for the development and commercialization of forodesine; and Shionogi & Co., Ltd. and Green Cross Corporation for the development and commercialization of peramivir. Biocryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.
Company Website :
  Privacy Policy  |   Terms of Use  |   Syndications  |   Contact Us